APO Research
Talk to an analyst

APO RESEARCH · REPORT

Diabetes Medicines

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Diabetes Medicines Industry Growth and Trends Forecast to 2032

28 December 2025118 pages

Choose your research edition.

Industry ResearchDiabetes Medicines Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Diabetes Medicines Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Diabetes Medicines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Diabetes Medicines Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Diabetes Medicines Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Diabetes Medicines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Diabetes Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Diabetes Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Diabetes Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Diabetes Medicines include Biocon, Boehringer Ingelheim, Geropharm, Wockhardt, AstraZeneca, bayer, Ganli Pharmaceutical, Jiangsu Wanbang and Conker Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Diabetes Medicines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Diabetes Medicines market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Diabetes Medicines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Diabetes Medicines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Diabetes Medicines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Diabetes Medicines Market by Company

Biocon

Boehringer Ingelheim

Geropharm

Wockhardt

AstraZeneca

bayer

Ganli Pharmaceutical

Jiangsu Wanbang

Conker Pharmaceuticals

Eli Lilly

United Pharmaceuticals

Merck Serono

Merck

Novo Nordisk

Novartis

Johnson & Johnson

Sanofi

Tonghua Dongbao

Takeda

Diabetes Medicines Segment by Type

Oral

Injection

Diabetes Medicines Segment by Application

Hospital

Retail Pharmacy

Diabetes Medicines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diabetes Medicines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Diabetes Medicines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diabetes Medicines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Diabetes Medicines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Diabetes Medicines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Oral Table 2. Major Company of Injection Table 3. Global Diabetes Medicines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Diabetes Medicines Sales by Type (2021-2026) & (K Units) Table 5. Global Diabetes Medicines Sales Market Share in Volume by Type (2021-2026) Table 6. Global Diabetes Medicines Sales by Type (2021-2026) & (US$ Million) Table 7. Global Diabetes Medicines Sales Market Share in Value by Type (2021-2026) Table 8. Global Diabetes Medicines Price by Type (2021-2026) & (US$/Unit) Table 9. Global Diabetes Medicines Sales by Type (2027-2032) & (K Units) Table 10. Global Diabetes Medicines Sales Market Share in Volume by Type (2027-2032) Table 11. Global Diabetes Medicines Sales by Type (2027-2032) & (US$ Million) Table 12. Global Diabetes Medicines Sales Market Share in Value by Type (2027-2032) Table 13. Global Diabetes Medicines Price by Type (2027-2032) & (US$/Unit) Table 14. North America Diabetes Medicines Sales by Type (2021-2026) & (K Units) Table 15. North America Diabetes Medicines Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Diabetes Medicines Sales by Type (2021-2026) & (K Units) Table 17. Europe Diabetes Medicines Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Diabetes Medicines Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Diabetes Medicines Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Diabetes Medicines Sales by Type (2021-2026) & (K Units) Table 21. Latin America Diabetes Medicines Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Diabetes Medicines Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Diabetes Medicines Sales by Type (2021-2026) & (US$ Million) Table 24. Diabetes Medicines Industry Trends Table 25. Diabetes Medicines Industry Drivers Table 26. Diabetes Medicines Industry Opportunities and Challenges Table 27. Diabetes Medicines Industry Restraints Table 28. Global Diabetes Medicines Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Diabetes Medicines Revenue Market Share by Company (2021-2026) Table 30. Global Diabetes Medicines Sales by Company (2021-2026) & (K Units) Table 31. Global Diabetes Medicines Sales Share by Company (2021-2026) Table 32. Global Diabetes Medicines Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Diabetes Medicines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Diabetes Medicines Major Company Production Sites and Headquarters Table 35. Global Diabetes Medicines Company, Product Type & Application Table 36. Global Diabetes Medicines Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Diabetes Medicines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Diabetes Medicines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Diabetes Medicines Sales by Region (2021-2026) & (K Units) Table 41. Global Diabetes Medicines Sales Market Share in Volume by Region (2021-2026) Table 42. Global Diabetes Medicines Sales by Region (2021-2026) & (US$ Million) Table 43. Global Diabetes Medicines Sales Market Share in Value by Region (2021-2026) Table 44. Global Diabetes Medicines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Diabetes Medicines Sales by Region (2027-2032) & (K Units) Table 46. Global Diabetes Medicines Sales Market Share in Volume by Region (2027-2032) Table 47. Global Diabetes Medicines Sales by Region (2027-2032) & (US$ Million) Table 48. Global Diabetes Medicines Sales Market Share in Value by Region (2027-2032) Table 49. Global Diabetes Medicines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Diabetes Medicines Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Diabetes Medicines Sales by Application (2021-2026) & (K Units) Table 52. Global Diabetes Medicines Sales Market Share in Volume by Application (2021-2026) Table 53. Global Diabetes Medicines Sales by Application (2021-2026) & (US$ Million) Table 54. Global Diabetes Medicines Sales Market Share in Value by Application (2021-2026) Table 55. Global Diabetes Medicines Price by Application (2021-2026) & (US$/Unit) Table 56. Global Diabetes Medicines Sales by Application (2027-2032) & (K Units) Table 57. Global Diabetes Medicines Sales Market Share in Volume by Application (2027-2032) Table 58. Global Diabetes Medicines Sales by Application (2027-2032) & (US$ Million) Table 59. Global Diabetes Medicines Sales Market Share in Value by Application (2027-2032) Table 60. Global Diabetes Medicines Price by Application (2027-2032) & (US$/Unit) Table 61. North America Diabetes Medicines Sales by Application (2021-2026) & (K Units) Table 62. North America Diabetes Medicines Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Diabetes Medicines Sales by Application (2021-2026) & (K Units) Table 64. Europe Diabetes Medicines Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Diabetes Medicines Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Diabetes Medicines Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Diabetes Medicines Sales by Application (2021-2026) & (K Units) Table 68. Latin America Diabetes Medicines Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Diabetes Medicines Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Diabetes Medicines Sales by Application (2021-2026) & (US$ Million) Table 71. Biocon Company Information Table 72. Biocon Business Overview Table 73. Biocon Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Biocon Diabetes Medicines Product Portfolio Table 75. Biocon Recent Development Table 76. Boehringer Ingelheim Company Information Table 77. Boehringer Ingelheim Business Overview Table 78. Boehringer Ingelheim Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Boehringer Ingelheim Diabetes Medicines Product Portfolio Table 80. Boehringer Ingelheim Recent Development Table 81. Geropharm Company Information Table 82. Geropharm Business Overview Table 83. Geropharm Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Geropharm Diabetes Medicines Product Portfolio Table 85. Geropharm Recent Development Table 86. Wockhardt Company Information Table 87. Wockhardt Business Overview Table 88. Wockhardt Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Wockhardt Diabetes Medicines Product Portfolio Table 90. Wockhardt Recent Development Table 91. AstraZeneca Company Information Table 92. AstraZeneca Business Overview Table 93. AstraZeneca Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. AstraZeneca Diabetes Medicines Product Portfolio Table 95. AstraZeneca Recent Development Table 96. bayer Company Information Table 97. bayer Business Overview Table 98. bayer Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. bayer Diabetes Medicines Product Portfolio Table 100. bayer Recent Development Table 101. Ganli Pharmaceutical Company Information Table 102. Ganli Pharmaceutical Business Overview Table 103. Ganli Pharmaceutical Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Ganli Pharmaceutical Diabetes Medicines Product Portfolio Table 105. Ganli Pharmaceutical Recent Development Table 106. Jiangsu Wanbang Company Information Table 107. Jiangsu Wanbang Business Overview Table 108. Jiangsu Wanbang Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Jiangsu Wanbang Diabetes Medicines Product Portfolio Table 110. Jiangsu Wanbang Recent Development Table 111. Conker Pharmaceuticals Company Information Table 112. Conker Pharmaceuticals Business Overview Table 113. Conker Pharmaceuticals Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Conker Pharmaceuticals Diabetes Medicines Product Portfolio Table 115. Conker Pharmaceuticals Recent Development Table 116. Eli Lilly Company Information Table 117. Eli Lilly Business Overview Table 118. Eli Lilly Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Eli Lilly Diabetes Medicines Product Portfolio Table 120. Eli Lilly Recent Development Table 121. United Pharmaceuticals Company Information Table 122. United Pharmaceuticals Business Overview Table 123. United Pharmaceuticals Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. United Pharmaceuticals Diabetes Medicines Product Portfolio Table 125. United Pharmaceuticals Recent Development Table 126. Merck Serono Company Information Table 127. Merck Serono Business Overview Table 128. Merck Serono Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Merck Serono Diabetes Medicines Product Portfolio Table 130. Merck Serono Recent Development Table 131. Merck Company Information Table 132. Merck Business Overview Table 133. Merck Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Merck Diabetes Medicines Product Portfolio Table 135. Merck Recent Development Table 136. Novo Nordisk Company Information Table 137. Novo Nordisk Business Overview Table 138. Novo Nordisk Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Novo Nordisk Diabetes Medicines Product Portfolio Table 140. Novo Nordisk Recent Development Table 141. Novartis Company Information Table 142. Novartis Business Overview Table 143. Novartis Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Novartis Diabetes Medicines Product Portfolio Table 145. Novartis Recent Development Table 146. Johnson & Johnson Company Information Table 147. Johnson & Johnson Business Overview Table 148. Johnson & Johnson Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Johnson & Johnson Diabetes Medicines Product Portfolio Table 150. Johnson & Johnson Recent Development Table 151. Sanofi Company Information Table 152. Sanofi Business Overview Table 153. Sanofi Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. Sanofi Diabetes Medicines Product Portfolio Table 155. Sanofi Recent Development Table 156. Tonghua Dongbao Company Information Table 157. Tonghua Dongbao Business Overview Table 158. Tonghua Dongbao Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 159. Tonghua Dongbao Diabetes Medicines Product Portfolio Table 160. Tonghua Dongbao Recent Development Table 161. Takeda Company Information Table 162. Takeda Business Overview Table 163. Takeda Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 164. Takeda Diabetes Medicines Product Portfolio Table 165. Takeda Recent Development Table 166. North America Diabetes Medicines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. North America Diabetes Medicines Sales by Country (2021-2026) & (K Units) Table 168. North America Diabetes Medicines Sales Market Share by Country (2021-2026) Table 169. North America Diabetes Medicines Sales Forecast by Country (2027-2032) & (K Units) Table 170. North America Diabetes Medicines Sales Market Share Forecast by Country (2027-2032) Table 171. North America Diabetes Medicines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. North America Diabetes Medicines Market Size by Country (2021-2026) & (US$ Million) Table 173. North America Diabetes Medicines Market Share by Country (2021-2026) Table 174. North America Diabetes Medicines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. North America Diabetes Medicines Market Share Forecast by Country (2027-2032) Table 176. Europe Diabetes Medicines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 177. Europe Diabetes Medicines Sales by Country (2021-2026) & (K Units) Table 178. Europe Diabetes Medicines Sales Market Share by Country (2021-2026) Table 179. Europe Diabetes Medicines Sales Forecast by Country (2027-2032) & (K Units) Table 180. Europe Diabetes Medicines Sales Market Share Forecast by Country (2027-2032) Table 181. Europe Diabetes Medicines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Europe Diabetes Medicines Market Size by Country (2021-2026) & (US$ Million) Table 183. Europe Diabetes Medicines Market Share by Country (2021-2026) Table 184. Europe Diabetes Medicines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Europe Diabetes Medicines Market Share Forecast by Country (2027-2032) Table 186. Asia-Pacific Diabetes Medicines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 187. Asia-Pacific Diabetes Medicines Sales by Country (2021-2026) & (K Units) Table 188. Asia-Pacific Diabetes Medicines Sales Market Share by Country (2021-2026) Table 189. Asia-Pacific Diabetes Medicines Sales Forecast by Country (2027-2032) & (K Units) Table 190. Asia-Pacific Diabetes Medicines Sales Market Share Forecast by Country (2027-2032) Table 191. Asia-Pacific Diabetes Medicines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Asia-Pacific Diabetes Medicines Market Size by Country (2021-2026) & (US$ Million) Table 193. Asia-Pacific Diabetes Medicines Market Share by Country (2021-2026) Table 194. Asia-Pacific Diabetes Medicines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Asia-Pacific Diabetes Medicines Market Share Forecast by Country (2027-2032) Table 196. Latin America Diabetes Medicines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 197. Latin America Diabetes Medicines Sales by Country (2021-2026) & (K Units) Table 198. Latin America Diabetes Medicines Sales Market Share by Country (2021-2026) Table 199. Latin America Diabetes Medicines Sales Forecast by Country (2027-2032) & (K Units) Table 200. Latin America Diabetes Medicines Sales Market Share Forecast by Country (2027-2032) Table 201. Latin America Diabetes Medicines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 202. Latin America Diabetes Medicines Market Size by Country (2021-2026) & (US$ Million) Table 203. Latin America Diabetes Medicines Market Share by Country (2021-2026) Table 204. Latin America Diabetes Medicines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 205. Latin America Diabetes Medicines Market Share Forecast by Country (2027-2032) Table 206. Middle East and Africa Diabetes Medicines Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 207. Middle East and Africa Diabetes Medicines Sales by Country (2021-2026) & (K Units) Table 208. Middle East and Africa Diabetes Medicines Sales Market Share by Country (2021-2026) Table 209. Middle East and Africa Diabetes Medicines Sales Forecast by Country (2027-2032) & (K Units) Table 210. Middle East and Africa Diabetes Medicines Sales Market Share Forecast by Country (2027-2032) Table 211. Middle East and Africa Diabetes Medicines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 212. Middle East and Africa Diabetes Medicines Market Size by Country (2021-2026) & (US$ Million) Table 213. Middle East and Africa Diabetes Medicines Market Share by Country (2021-2026) Table 214. Middle East and Africa Diabetes Medicines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 215. Middle East and Africa Diabetes Medicines Market Share Forecast by Country (2027-2032) Table 216. Key Raw Materials Table 217. Raw Materials Key Suppliers Table 218. Diabetes Medicines Distributors List Table 219. Diabetes Medicines Customers List Table 220. Research Programs/Design for This Report Table 221. Authors List of This Report Table 222. Secondary Sources Table 223. Primary Sources List of Figures Figure 1. Diabetes Medicines Image Figure 2. Global Diabetes Medicines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Diabetes Medicines Market Size (2021-2032) & (US$ Million) Figure 4. Global Diabetes Medicines Sales (2021-2032) & (K Units) Figure 5. Oral Image Figure 6. Global Oral Sales YoY Growth (2021-2032) & (K Units) Figure 7. Injection Image Figure 8. Global Injection Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Diabetes Medicines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Diabetes Medicines Market Share by Type 2025 VS 2032 Figure 11. North America Diabetes Medicines Sales Market Share in Volume by Type in 2025 Figure 12. North America Diabetes Medicines Sales Market Share in Value by Type in 2025 Figure 13. Europe Diabetes Medicines Sales Market Share in Volume by Type in 2025 Figure 14. Europe Diabetes Medicines Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Diabetes Medicines Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Diabetes Medicines Sales Market Share in Value by Type in 2025 Figure 17. Latin America Diabetes Medicines Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Diabetes Medicines Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Diabetes Medicines Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Diabetes Medicines Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Diabetes Medicines Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Retail Pharmacy Image Figure 26. Global Retail Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Diabetes Medicines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Diabetes Medicines Market Share by Application 2025 VS 2032 Figure 29. North America Diabetes Medicines Sales Market Share in Volume by Application in 2025 Figure 30. North America Diabetes Medicines Sales Market Share in Value by Application in 2025 Figure 31. Europe Diabetes Medicines Sales Market Share in Volume by Application in 2025 Figure 32. Europe Diabetes Medicines Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Diabetes Medicines Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Diabetes Medicines Sales Market Share in Value by Application in 2025 Figure 35. Latin America Diabetes Medicines Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Diabetes Medicines Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Diabetes Medicines Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Diabetes Medicines Sales Market Share in Value by Application in 2025 Figure 39. North America Diabetes Medicines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Diabetes Medicines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Diabetes Medicines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Diabetes Medicines Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Diabetes Medicines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Diabetes Medicines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Diabetes Medicines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Diabetes Medicines Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Diabetes Medicines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Diabetes Medicines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Diabetes Medicines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Diabetes Medicines Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Diabetes Medicines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Diabetes Medicines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Diabetes Medicines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Diabetes Medicines Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Diabetes Medicines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Diabetes Medicines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Diabetes Medicines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Diabetes Medicines Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Diabetes Medicines Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Diabetes Medicines Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Injection
Applications
  • Hospital
  • Retail Pharmacy
Companies covered
  • Biocon
  • Boehringer Ingelheim
  • Geropharm
  • Wockhardt
  • AstraZeneca
  • bayer
  • Ganli Pharmaceutical
  • Jiangsu Wanbang
  • Conker Pharmaceuticals
  • Eli Lilly
  • United Pharmaceuticals
  • Merck Serono
  • Merck
  • Novo Nordisk
  • Novartis
  • Johnson & Johnson
  • Sanofi
  • Tonghua Dongbao
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Diabetes Medicines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Diabetes Medicines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Diabetes Medicines Market by Type
  6. 1.3.1 Oral
  7. 1.3.2 Injection
  8. 1.4 Global Diabetes Medicines Market Size by Type
  9. 1.4.1 Global Diabetes Medicines Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Diabetes Medicines Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Diabetes Medicines Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Diabetes Medicines Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Diabetes Medicines Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Diabetes Medicines Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Diabetes Medicines Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Diabetes Medicines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Diabetes Medicines Industry Trends
  2. 2.2 Diabetes Medicines Industry Drivers
  3. 2.3 Diabetes Medicines Industry Opportunities and Challenges
  4. 2.4 Diabetes Medicines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Diabetes Medicines Revenue (2021-2026)
  2. 3.2 Global Top Players by Diabetes Medicines Sales (2021-2026)
  3. 3.3 Global Top Players by Diabetes Medicines Price (2021-2026)
  4. 3.4 Global Diabetes Medicines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Diabetes Medicines Major Company Production Sites & Headquarters
  6. 3.6 Global Diabetes Medicines Company, Product Type & Application
  7. 3.7 Global Diabetes Medicines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Diabetes Medicines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Diabetes Medicines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Diabetes Medicines Tier 1, Tier 2, and Tier 3
4 Diabetes Medicines Regional Status and Outlook
  1. 4.1 Global Diabetes Medicines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Diabetes Medicines Historic Market Size by Region
  3. 4.2.1 Global Diabetes Medicines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Diabetes Medicines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Diabetes Medicines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Diabetes Medicines Forecasted Market Size by Region
  7. 4.3.1 Global Diabetes Medicines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Diabetes Medicines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Diabetes Medicines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Diabetes Medicines by Application
  1. 5.1 Diabetes Medicines Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Retail Pharmacy
  4. 5.2 Global Diabetes Medicines Market Size by Application
  5. 5.2.1 Global Diabetes Medicines Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Diabetes Medicines Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Diabetes Medicines Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Diabetes Medicines Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Diabetes Medicines Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Diabetes Medicines Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Diabetes Medicines Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Diabetes Medicines Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Biocon
  2. 6.1.1 Biocon Company Information
  3. 6.1.2 Biocon Business Overview
  4. 6.1.3 Biocon Diabetes Medicines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Biocon Diabetes Medicines Product Portfolio
  6. 6.1.5 Biocon Recent Developments
  7. 6.2 Boehringer Ingelheim
  8. 6.2.1 Boehringer Ingelheim Company Information
  9. 6.2.2 Boehringer Ingelheim Business Overview
  10. 6.2.3 Boehringer Ingelheim Diabetes Medicines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Boehringer Ingelheim Diabetes Medicines Product Portfolio
  12. 6.2.5 Boehringer Ingelheim Recent Developments
  13. 6.3 Geropharm
  14. 6.3.1 Geropharm Company Information
  15. 6.3.2 Geropharm Business Overview
  16. 6.3.3 Geropharm Diabetes Medicines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Geropharm Diabetes Medicines Product Portfolio
  18. 6.3.5 Geropharm Recent Developments
  19. 6.4 Wockhardt
  20. 6.4.1 Wockhardt Company Information
  21. 6.4.2 Wockhardt Business Overview
  22. 6.4.3 Wockhardt Diabetes Medicines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Wockhardt Diabetes Medicines Product Portfolio
  24. 6.4.5 Wockhardt Recent Developments
  25. 6.5 AstraZeneca
  26. 6.5.1 AstraZeneca Company Information
  27. 6.5.2 AstraZeneca Business Overview
  28. 6.5.3 AstraZeneca Diabetes Medicines Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 AstraZeneca Diabetes Medicines Product Portfolio
  30. 6.5.5 AstraZeneca Recent Developments
  31. 6.6 bayer
  32. 6.6.1 bayer Company Information
  33. 6.6.2 bayer Business Overview
  34. 6.6.3 bayer Diabetes Medicines Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 bayer Diabetes Medicines Product Portfolio
  36. 6.6.5 bayer Recent Developments
  37. 6.7 Ganli Pharmaceutical
  38. 6.7.1 Ganli Pharmaceutical Company Information
  39. 6.7.2 Ganli Pharmaceutical Business Overview
  40. 6.7.3 Ganli Pharmaceutical Diabetes Medicines Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Ganli Pharmaceutical Diabetes Medicines Product Portfolio
  42. 6.7.5 Ganli Pharmaceutical Recent Developments
  43. 6.8 Jiangsu Wanbang
  44. 6.8.1 Jiangsu Wanbang Company Information
  45. 6.8.2 Jiangsu Wanbang Business Overview
  46. 6.8.3 Jiangsu Wanbang Diabetes Medicines Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Jiangsu Wanbang Diabetes Medicines Product Portfolio
  48. 6.8.5 Jiangsu Wanbang Recent Developments
  49. 6.9 Conker Pharmaceuticals
  50. 6.9.1 Conker Pharmaceuticals Company Information
  51. 6.9.2 Conker Pharmaceuticals Business Overview
  52. 6.9.3 Conker Pharmaceuticals Diabetes Medicines Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Conker Pharmaceuticals Diabetes Medicines Product Portfolio
  54. 6.9.5 Conker Pharmaceuticals Recent Developments
  55. 6.10 Eli Lilly
  56. 6.10.1 Eli Lilly Company Information
  57. 6.10.2 Eli Lilly Business Overview
  58. 6.10.3 Eli Lilly Diabetes Medicines Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Eli Lilly Diabetes Medicines Product Portfolio
  60. 6.10.5 Eli Lilly Recent Developments
  61. 6.11 United Pharmaceuticals
  62. 6.11.1 United Pharmaceuticals Company Information
  63. 6.11.2 United Pharmaceuticals Business Overview
  64. 6.11.3 United Pharmaceuticals Diabetes Medicines Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 United Pharmaceuticals Diabetes Medicines Product Portfolio
  66. 6.11.5 United Pharmaceuticals Recent Developments
  67. 6.12 Merck Serono
  68. 6.12.1 Merck Serono Company Information
  69. 6.12.2 Merck Serono Business Overview
  70. 6.12.3 Merck Serono Diabetes Medicines Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Merck Serono Diabetes Medicines Product Portfolio
  72. 6.12.5 Merck Serono Recent Developments
  73. 6.13 Merck
  74. 6.13.1 Merck Company Information
  75. 6.13.2 Merck Business Overview
  76. 6.13.3 Merck Diabetes Medicines Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Merck Diabetes Medicines Product Portfolio
  78. 6.13.5 Merck Recent Developments
  79. 6.14 Novo Nordisk
  80. 6.14.1 Novo Nordisk Company Information
  81. 6.14.2 Novo Nordisk Business Overview
  82. 6.14.3 Novo Nordisk Diabetes Medicines Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Novo Nordisk Diabetes Medicines Product Portfolio
  84. 6.14.5 Novo Nordisk Recent Developments
  85. 6.15 Novartis
  86. 6.15.1 Novartis Company Information
  87. 6.15.2 Novartis Business Overview
  88. 6.15.3 Novartis Diabetes Medicines Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Novartis Diabetes Medicines Product Portfolio
  90. 6.15.5 Novartis Recent Developments
  91. 6.16 Johnson & Johnson
  92. 6.16.1 Johnson & Johnson Company Information
  93. 6.16.2 Johnson & Johnson Business Overview
  94. 6.16.3 Johnson & Johnson Diabetes Medicines Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Johnson & Johnson Diabetes Medicines Product Portfolio
  96. 6.16.5 Johnson & Johnson Recent Developments
  97. 6.17 Sanofi
  98. 6.17.1 Sanofi Company Information
  99. 6.17.2 Sanofi Business Overview
  100. 6.17.3 Sanofi Diabetes Medicines Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Sanofi Diabetes Medicines Product Portfolio
  102. 6.17.5 Sanofi Recent Developments
  103. 6.18 Tonghua Dongbao
  104. 6.18.1 Tonghua Dongbao Company Information
  105. 6.18.2 Tonghua Dongbao Business Overview
  106. 6.18.3 Tonghua Dongbao Diabetes Medicines Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Tonghua Dongbao Diabetes Medicines Product Portfolio
  108. 6.18.5 Tonghua Dongbao Recent Developments
  109. 6.19 Takeda
  110. 6.19.1 Takeda Company Information
  111. 6.19.2 Takeda Business Overview
  112. 6.19.3 Takeda Diabetes Medicines Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Takeda Diabetes Medicines Product Portfolio
  114. 6.19.5 Takeda Recent Developments
7 North America by Country
  1. 7.1 North America Diabetes Medicines Sales by Country
  2. 7.1.1 North America Diabetes Medicines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Diabetes Medicines Sales by Country (2021-2026)
  4. 7.1.3 North America Diabetes Medicines Sales Forecast by Country (2027-2032)
  5. 7.2 North America Diabetes Medicines Market Size by Country
  6. 7.2.1 North America Diabetes Medicines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Diabetes Medicines Market Size by Country (2021-2026)
  8. 7.2.3 North America Diabetes Medicines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Diabetes Medicines Sales by Country
  2. 8.1.1 Europe Diabetes Medicines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Diabetes Medicines Sales by Country (2021-2026)
  4. 8.1.3 Europe Diabetes Medicines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Diabetes Medicines Market Size by Country
  6. 8.2.1 Europe Diabetes Medicines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Diabetes Medicines Market Size by Country (2021-2026)
  8. 8.2.3 Europe Diabetes Medicines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Diabetes Medicines Sales by Country
  2. 9.1.1 Asia-Pacific Diabetes Medicines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Diabetes Medicines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Diabetes Medicines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Diabetes Medicines Market Size by Country
  6. 9.2.1 Asia-Pacific Diabetes Medicines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Diabetes Medicines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Diabetes Medicines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Diabetes Medicines Sales by Country
  2. 10.1.1 South America Diabetes Medicines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Diabetes Medicines Sales by Country (2021-2026)
  4. 10.1.3 South America Diabetes Medicines Sales Forecast by Country (2027-2032)
  5. 10.2 South America Diabetes Medicines Market Size by Country
  6. 10.2.1 South America Diabetes Medicines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Diabetes Medicines Market Size by Country (2021-2026)
  8. 10.2.3 South America Diabetes Medicines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Diabetes Medicines Sales by Country
  2. 11.1.1 Middle East and Africa Diabetes Medicines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Diabetes Medicines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Diabetes Medicines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Diabetes Medicines Market Size by Country
  6. 11.2.1 Middle East and Africa Diabetes Medicines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Diabetes Medicines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Diabetes Medicines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Diabetes Medicines Value Chain Analysis
  2. 12.1.1 Diabetes Medicines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Diabetes Medicines Production Mode & Process
  7. 12.2 Diabetes Medicines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Diabetes Medicines Distributors
  10. 12.2.3 Diabetes Medicines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst